"Challenges and Earnings: Walgreens' Fiscal 2024 Q2 Results"

1 min read
Source: Walgreens Boots Alliance
"Challenges and Earnings: Walgreens' Fiscal 2024 Q2 Results"
Photo: Walgreens Boots Alliance
TL;DR

Walgreens Boots Alliance reported its fiscal 2024 second quarter results, with a 6.3% increase in sales to $37.1 billion, but also a $5.8 billion non-cash impairment charge related to VillageMD goodwill, resulting in a $6.85 loss per share. The company narrowed its full-year adjusted EPS guidance range to $3.20 to $3.35 due to a challenging retail environment in the U.S. and other factors. The U.S. Healthcare segment achieved adjusted EBITDA profitability, and the company remains focused on customer engagement and value amidst ongoing operational challenges.

Share this article

Want the full story? Read the original reporting

Read on Walgreens Boots Alliance